Connor McMahon was treated at a children’s hospital in Atlanta for leukemia, first at three years old, then eight years later when he was 12. When he relapsed again at 15, he traveled to Duke for a clinical trial of a first-of-its kind treatment.

Twitter recently announced it had suspended 125,000 accounts since the middle of 2015 “for threatening or promoting terrorist acts, primarily related to ISIS.”

Joseph Odell Moore, MD, celebrated his 75th birthday, and after 44 years, retired from clinical practice as a DCI hematologic oncologist.

(RNS) As part of his “Islam in Film” class at the University of Nebraska, religious studies professor Kristian Petersen screens movies such as “The Hurt Locker” , “Argo” and “American Sniper” to make the point that depictions of Muslims on the big...

On a crisp night last month nearly all 22 students learning Turkish at UNC-Chapel Hill and Duke University took advantage of a unique opportunity to practice their Turkish with Nobel prize winner Aziz Sancar at his Türk Evi (Turkish House)...

The journey of a new drug for advanced breast cancer.

Duke Cancer Institute has given stage 4 cancer survivor Milos Bogetic precious extra time with his wife and growing young son.

Elle was the first patient accrued to the Duke-initiated "Mountaineer" study, a clinical trial for CRC patients with a HER2 amplification. She was a trailblazer. It worked. Here is HERstory and the HIStory behind her oncologist's novel approach.

An event earlier this month included a Ramadan quiz, a slideshow of Ramadan and Eid al-Fitr commemorations, and a Pakistani and Mediterranean buffet dinner. But this was a not a meet-your-Muslim-neighbor event at the local mosque.

"It's my comfort spot. I can live my life when I’m here, even if I’m not feeling well, and they are always here to take care of me.”

For 20 years, Nadine Barrett, PhD, has worked to reduce health disparities among underrepresented populations by increasing their access to care and research.

While HPV-associated oropharynx cancer remains a relatively rare cancer in the U.S., it's now the most common type of head and neck cancer and the number of cases is rising, some say to epidemic proportions. Here is Robert Russell's survival story.

Palestinian journalist Laila El-Haddad prepares to deliver a public talk to a room packed with academics and foodies from the Duke community and local area. The topic — “The Gaza Kitchen: Cuisine, Resistance, and Remembrance in Palestine.”

In January 2018, DCI joined a select group of medical centers authorized to offer a new type of immunotherapy — CAR T — for patients with certain types of relapsed or refractory non-Hodgkin’s lymphoma.

On Thursday, April 14, 2022, DCI clinical providers, patients, researchers, staff, and leadership came together to celebrate the 50th anniversary of the Duke Comprehensive Cancer Center (now called Duke Cancer Institute).

The Southeastern American Indian Cancer Health Equity Partnership seeks to address the stark disparities in cancer health experienced by American Indian communities. NC has the largest American Indian population in the Eastern U.S.

When a Galapagos tortoise suffering from sarcoma needed help in 1983, zookeepers at the Staten Island Zoo called Mark Dewhirst, DVM, PhD, a young scientist at University of Arizona. In 1984 he was recruited to DCI for his work in hyperthermia.

In a lot of ways, Susan Blackwell (Crawford), MHS, PA-C’89, and the physician assistant profession have grown up together.

Used to rescuing others in medical distress, Jerry Sams never expected to be the one in need of saving.

Omidubicel, a novel cellular therapy, expands the availability of donor stem cell transplants to more patients.